Yang Yang, Xie Zexin, Zhang Jiantao, Zhou Xuetao, Liang Zheng, Hou Chunjuan, Zhang Jin, Zhang Dongsheng
Department of Cardiothoracic Surgery, The Third Hospital of Shijiazhuang, ShijiazhuangHebei, 050011, China.
Department of Thoracic Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Qingdao, 264000, Sandong, China.
World J Emerg Surg. 2025 Jun 24;20(1):54. doi: 10.1186/s13017-025-00629-z.
This study aimed to investigate the surgical outcomes and complications of completely thoracoscopic surgical stabilization of rib fractures (cTSSRF) in patients with rib fractures in the posterior chest wall area.
A retrospective analysis was conducted on 30 patients who underwent completely thoracoscopic surgical stabilization of rib fractures (cTSSRF) between September 2019 and October 2023. Clinical data were gathered to compare and analyze the clinical outcomes of complications of cTSSRF and open surgical stabilization of rib fractures (oSSRF).
A total of 201 rib fractures were repaired in 30 patients, including 79 rib fractures in the posterior chest wall (an average of 2.63 rib fractures/person) that were fixed by cTSSRF, and 122 rib fractures (an average of 4.06 rib fractures/person) fixed by oSSRF. No obvious thoracic collapse deformity was observed postoperatively in any patient. The median duration of chest tube removal after surgery was 3 (3-4) days, and the chest drainage volume was 586.33 ± 232.4 ml. The numeric rating scale score (NRS) was 3 (2-3.25), which was significantly lower than the preoperative score of 7 (6-8), z = -4.826, P < 0.001). The rate of implant displacement of the cTSSRF was 6.33% (5/79), which was significantly higher than that in the oSSRF of 0(0/122), χ2 = 5.53, P = 0.019. The rates of fracture malalignment were high in the cTSSRF (21.52% [20/79] vs2.46% [3/122], P < 0.001). The incidence of postoperative encapsulated pleural effusion-defined as a maximum anteroposterior fluid thickness > 20 mm surrounding the internal fixation device on axial CT scans-was 46.7% (14/30 cases) during the 7-14 day postoperative period. All patients were followed-up in outpatient clinics or by telephone for 6-24 months, and all resumed their work capacity without obvious symptoms of chest discomfort.
The application of cTSSRF is a safe, feasible and minimally invasive surgical option, particularly in cases of rib fractures in the posterior chest wall, which are challenging to address using conventional open surgery. However, the postoperative implant displacement and fracture malalignment rates are higher than those observed in conventional surgery, which still needs to require careful evaluation of the risks and benefits of routinely performing cTSSRF.
本研究旨在探讨完全胸腔镜下肋骨骨折手术固定(cTSSRF)治疗后胸壁区域肋骨骨折患者的手术效果及并发症。
对2019年9月至2023年10月期间接受完全胸腔镜下肋骨骨折手术固定(cTSSRF)的30例患者进行回顾性分析。收集临床资料,比较并分析cTSSRF与开放性肋骨骨折手术固定(oSSRF)的临床结局及并发症。
30例患者共修复201处肋骨骨折,其中后胸壁79处肋骨骨折(平均每人2.63处)采用cTSSRF固定,122处肋骨骨折(平均每人4.06处)采用oSSRF固定。术后所有患者均未观察到明显的胸廓塌陷畸形。术后胸腔闭式引流管拔除的中位时间为3(3 - 4)天,胸腔引流量为586.33±232.4ml。数字评分量表(NRS)评分术后为3(2 - 3.25),显著低于术前的7(6 - 8)分,z = -4.826,P < 0.001)。cTSSRF的植入物移位率为6.33%(5/79),显著高于oSSRF的0(0/122),χ2 = 5.53,P = 0.019。cTSSRF的骨折对位不良率较高(21.52%[20/79] vs 2.46%[3/122],P < 0.001)。术后7 - 14天期间,术后包裹性胸腔积液(定义为轴向CT扫描显示内固定装置周围最大前后液性厚度>20mm)的发生率为46.7%(14/30例)。所有患者在门诊或通过电话随访6 - 24个月,均恢复工作能力,无明显胸部不适症状。
cTSSRF的应用是一种安全、可行且微创的手术选择,尤其适用于后胸壁肋骨骨折,而传统开放手术处理此类骨折具有挑战性。然而,其术后植入物移位和骨折对位不良率高于传统手术,仍需仔细评估常规进行cTSSRF的风险和益处。